Medistim ASA historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-12-01 | 257.00 | 259.00 | 257.00 | 259.00 | 249.87 | 104 |
| 2025-11-27 | 249.50 | 249.50 | 246.00 | 246.00 | 237.33 | 884 |
| 2025-11-26 | 247.00 | 248.00 | 246.00 | 246.00 | 237.33 | 889 |
| 2025-11-25 | 246.00 | 246.00 | 246.00 | 246.00 | 237.33 | 98 |
| 2025-11-24 | 247.50 | 247.50 | 247.50 | 247.50 | 238.78 | 4 |
| 2025-11-21 | 249.00 | 254.00 | 249.00 | 254.00 | 245.05 | 32 |
| 2025-11-20 | 249.00 | 251.00 | 249.00 | 251.00 | 242.15 | 80 |
| 2025-11-19 | 254.00 | 254.00 | 246.00 | 246.00 | 237.33 | 950 |
| 2025-11-18 | 250.00 | 250.00 | 250.00 | 250.00 | 241.19 | 98 |
| 2025-11-17 | 240.00 | 242.00 | 240.00 | 242.00 | 233.47 | 1,776 |
| 2025-11-14 | 240.00 | 240.00 | 238.00 | 238.00 | 229.61 | 1,044 |
| 2025-11-13 | 250.00 | 250.00 | 250.00 | 250.00 | 241.19 | 268 |
| 2025-11-12 | 248.00 | 248.00 | 248.00 | 248.00 | 239.26 | 25 |
| 2025-11-11 | 257.00 | 257.00 | 255.50 | 255.50 | 246.50 | 156 |
| 2025-11-10 | 254.00 | 254.00 | 252.00 | 252.00 | 243.12 | 1,031 |
| 2025-11-07 | 248.00 | 248.00 | 244.00 | 244.00 | 235.40 | 300 |
| 2025-11-05 | 263.00 | 263.00 | 262.00 | 262.00 | 252.77 | 1,947 |
| 2025-10-31 | 274.00 | 274.00 | 274.00 | 274.00 | 264.34 | 1,045 |
| 2025-10-30 | 272.00 | 272.00 | 272.00 | 272.00 | 262.41 | 50 |
| 2025-10-29 | 284.00 | 284.00 | 284.00 | 284.00 | 273.99 | 187 |
| 2025-10-28 | 286.00 | 288.00 | 285.00 | 285.00 | 274.96 | 231 |
| 2025-10-27 | 274.00 | 286.00 | 273.00 | 280.50 | 270.61 | 1,290 |
← NewerPage 4 of 4 · 202 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2026-05-07 | 8.0000 NOK |
| 2025-05-09 | 6.0000 NOK |
| 2024-04-25 | 4.5000 NOK |
| 2023-04-25 | 4.5000 NOK |
| 2022-04-28 | 3.7500 NOK |
| 2021-04-28 | 3.0000 NOK |
| 2020-10-22 | 2.7500 NOK |
| 2019-04-25 | 2.2500 NOK |
Open, high, low and close are as traded (NOK). Adjusted close accounts for splits and dividends. Educational only, not financial advice.